CYTOKINETICS INC - COMMON STOCK (CYTK)

Historical Holders from Q1 2014 to Q1 2025

Symbol
CYTK on Nasdaq
CUSIP
23282W605
Type / Class
Equity / COMMON STOCK
Shares outstanding
119M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
131M
Holdings value
$6.18B
% of all portfolios
0.012%
Grand Portfolio weight change
0%
Number of holders
347
Number of buys
148
Number of sells
-174
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.006%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CYTOKINETICS INC - COMMON STOCK (CYTK)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10.09% $479M 11.9M The Vanguard Group Dec 31, 2024
FMR LLC 9.4% $448M 11.1M FMR LLC Dec 31, 2024

Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 1.18M $47.5M +$15.8M $40.19 34
2024 Q4 131M $6.18B -$259M $47.04 347
2024 Q3 135M $7.13B -$76.1M $52.80 348
2024 Q2 135M $7.34B +$959M $54.18 351
2024 Q1 117M $8.18B +$220M $70.11 392
2023 Q4 114M $9.53B +$204M $83.49 337
2023 Q3 108M $3.19B +$11M $29.46 244
2023 Q2 107M $3.48B -$38.3M $32.62 246
2023 Q1 108M $3.78B +$68.6M $35.19 255
2022 Q4 106M $4.88B +$70M $45.82 269
2022 Q3 89.7M $4.35B -$100M $48.45 262
2022 Q2 91.9M $3.61B +$407M $39.29 249
2022 Q1 81.8M $3.01B +$152M $36.81 225
2021 Q4 90.1M $4.1B +$33.3M $45.58 238
2021 Q3 89.2M $3.18B +$488M $35.74 201
2021 Q2 75.5M $1.49B +$7.76M $19.79 181
2021 Q1 74.7M $1.74B +$70.9M $23.26 186
2020 Q4 72.4M $1.5B -$7.2M $20.78 173
2020 Q3 68.8M $1.49B +$224M $21.65 176
2020 Q2 57.9M $1.36B +$106M $23.57 154
2020 Q1 52.6M $620M -$6.06M $11.79 137
2019 Q4 54.3M $576M +$111M $10.61 135
2019 Q3 42.7M $486M +$8.02M $11.38 137
2019 Q2 42.1M $473M +$63.7M $11.25 126
2019 Q1 39M $316M +$3.21M $8.09 122
2018 Q4 39.5M $250M +$228K $6.32 119
2018 Q3 38.2M $377M +$11.8M $9.85 110
2018 Q2 37.5M $311M +$5.85M $8.30 119
2018 Q1 36.8M $265M -$12.3M $7.20 118
2017 Q4 38.4M $313M -$31.6M $8.15 124
2017 Q3 39M $565M +$21.9M $14.50 125
2017 Q2 38.1M $461M +$119M $12.10 133
2017 Q1 28M $360M +$62.6M $12.85 102
2016 Q4 26.4M $321M -$2.12M $12.15 97
2016 Q3 26.7M $245M +$491K $9.18 87
2016 Q2 26.5M $252M +$5.26M $9.49 92
2016 Q1 26.6M $187M -$3.87M $7.05 103
2015 Q4 26.5M $277M +$55.3M $10.46 124
2015 Q3 21.6M $145M +$6.05M $6.69 102
2015 Q2 20.4M $137M +$7.72M $6.72 93
2015 Q1 19.6M $133M +$965K $6.78 91
2014 Q4 19.1M $153M +$252K $8.01 83
2014 Q3 19.8M $69.6M -$7.58M $3.52 80
2014 Q2 20.8M $99.2M -$24.7M $4.78 84
2014 Q1 22.5M $214M +$40M $9.50 103